BioCentury | Jan 14, 2013
Financial News

Tvax Biomedical completes venture financing

Tvax Biomedical Inc. , Lenexa, Kan. Business: Cancer, Infectious Date completed: 1/7/13 Type: Venture financing Raised: $2 million Investors: Not disclosed Note: Tvax raised $2 million in the first close of a planned $10 million financing...
BioCentury | Jan 14, 2013
Company News

Tvax Biomedical management update

Tvax Biomedical Inc. , Lenexa, Kan. Business: Cancer, Infectious Hired: Philip Haworth as CEO, formerly CEO of Silence Therapeutics plc ; he succeeds Gary Wood, who becomes CSO WIR Staff cancer Infectious...
BioCentury | May 21, 2012
Financial News

Tvax Biomedical withdraws IPO

Tvax Biomedical Inc. , Lenexa, Kan. Business: Cancer, Infectious Date announced: 5/17/12 Type: IPO Underwriters: Roth Capital Partners; Cantor Fitzgerald; Aegis Capital Note: Tvax withdrew its IPO, citing market conditions. WIR Staff cancer Infectious...
BioCentury | May 18, 2012
Financial News

Tvax pulls IPO

...Cancer company Tvax Biomedical Inc. (Lenexa, Kan.) withdrew its planned IPO, citing market conditions. The company had planned...
BioCentury | Apr 2, 2012
Finance

Some like it hot

...12/30/11 Up to $50M Mkt (diagnostic) Rib-X Pharmaceuticals Inc. 11/25/11 Up to $80M Ph II Tvax Biomedical Inc....
BioCentury | Jan 30, 2012
Financial News

Tvax Biomedical amends IPO

Tvax Biomedical Inc. , Lenexa, Kan. Business: Cancer, Infectious Date announced: 1/23/12 Type: IPO To be raised: Up to $25.3 million Shares: 2 million Price: $9-$11 Underwriters: Roth Capital Partners; Cantor Fitzgerald; Aegis Capital Overallotment: 300,000...
BioCentury | Jan 24, 2012
Financial News

Tvax sets IPO range

...Cancer company Tvax Biomedical Inc. (Lenexa, Kan.) amended its IPO and now plans to sell 2 million shares...
BioCentury | Jan 2, 2012
Finance

Living creatively

...filed To be raised Status (A) Rib-X Pharmaceuticals Inc. 11/25/11 Up to $80M Ph II Tvax Biomedical Inc....
BioCentury | Nov 14, 2011
Finance

Heartland IPOs

...was up $0.08 to $7.08 in its first day of trading on Friday. Meanwhile, Kansas-based Tvax Biomedical Inc....
BioCentury | Nov 14, 2011
Financial News

Tvax Biomedical proposes IPO

Tvax Biomedical Inc. , Lenexa, Kan. Business: Cancer, Infectious Date announced: 11/7/11 Type: IPO To be raised: Up to $40 million Shares: TBD Price: TBD Underwriters: Roth Capital Partners; Cantor Fitzgerald; Morgan Joseph TriArtisan WIR Staff...
Items per page:
1 - 10 of 11
BioCentury | Jan 14, 2013
Financial News

Tvax Biomedical completes venture financing

Tvax Biomedical Inc. , Lenexa, Kan. Business: Cancer, Infectious Date completed: 1/7/13 Type: Venture financing Raised: $2 million Investors: Not disclosed Note: Tvax raised $2 million in the first close of a planned $10 million financing...
BioCentury | Jan 14, 2013
Company News

Tvax Biomedical management update

Tvax Biomedical Inc. , Lenexa, Kan. Business: Cancer, Infectious Hired: Philip Haworth as CEO, formerly CEO of Silence Therapeutics plc ; he succeeds Gary Wood, who becomes CSO WIR Staff cancer Infectious...
BioCentury | May 21, 2012
Financial News

Tvax Biomedical withdraws IPO

Tvax Biomedical Inc. , Lenexa, Kan. Business: Cancer, Infectious Date announced: 5/17/12 Type: IPO Underwriters: Roth Capital Partners; Cantor Fitzgerald; Aegis Capital Note: Tvax withdrew its IPO, citing market conditions. WIR Staff cancer Infectious...
BioCentury | May 18, 2012
Financial News

Tvax pulls IPO

...Cancer company Tvax Biomedical Inc. (Lenexa, Kan.) withdrew its planned IPO, citing market conditions. The company had planned...
BioCentury | Apr 2, 2012
Finance

Some like it hot

...12/30/11 Up to $50M Mkt (diagnostic) Rib-X Pharmaceuticals Inc. 11/25/11 Up to $80M Ph II Tvax Biomedical Inc....
BioCentury | Jan 30, 2012
Financial News

Tvax Biomedical amends IPO

Tvax Biomedical Inc. , Lenexa, Kan. Business: Cancer, Infectious Date announced: 1/23/12 Type: IPO To be raised: Up to $25.3 million Shares: 2 million Price: $9-$11 Underwriters: Roth Capital Partners; Cantor Fitzgerald; Aegis Capital Overallotment: 300,000...
BioCentury | Jan 24, 2012
Financial News

Tvax sets IPO range

...Cancer company Tvax Biomedical Inc. (Lenexa, Kan.) amended its IPO and now plans to sell 2 million shares...
BioCentury | Jan 2, 2012
Finance

Living creatively

...filed To be raised Status (A) Rib-X Pharmaceuticals Inc. 11/25/11 Up to $80M Ph II Tvax Biomedical Inc....
BioCentury | Nov 14, 2011
Finance

Heartland IPOs

...was up $0.08 to $7.08 in its first day of trading on Friday. Meanwhile, Kansas-based Tvax Biomedical Inc....
BioCentury | Nov 14, 2011
Financial News

Tvax Biomedical proposes IPO

Tvax Biomedical Inc. , Lenexa, Kan. Business: Cancer, Infectious Date announced: 11/7/11 Type: IPO To be raised: Up to $40 million Shares: TBD Price: TBD Underwriters: Roth Capital Partners; Cantor Fitzgerald; Morgan Joseph TriArtisan WIR Staff...
Items per page:
1 - 10 of 11